Merck to evaluate Variational AI’s Enki™ generative AI platform to design novel and selective small molecules
Variational AI, developer of the Enki™ generative artificial intelligence...
BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Dr. Joerg Moeller as Chief Executive Officer and...
Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced that it has been included in a recent Gartner report,...
Anagenex and Nimbus Therapeutics (Nimbus) announced they have initiated a research collaboration. Anagenex, a pioneering drug discovery company pairing large-scale data generation with proprietary...
New AI-enabled, integrated workflow provides pharma and biotech companies with comprehensive R&D insights to help minimize late-stage failures during clinical trials
Clarivate Plc, a global...
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt Germany, a leading science and technology company, launched its AIDDISON™ drug discovery...
Bayer and US-based Recursion Pharmaceuticals, Inc., a clinical stage TechBio company decoding biology to industrialize drug discovery, announced that they have updated the focus...